Characterization of vascular effects of rosiglitazone.
Latest Information Update: 30 Sep 2013
At a glance
- Drugs Rosiglitazone (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 02 Oct 2006 Status change
- 18 Dec 2005 New trial record.